Stock comparison
REVVITY, INC. is 1.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($12.60 B vs $8.09 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
RVTY is larger
REVVITY, INC. is 1.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($12.60 B vs $8.09 B).
Market value leader
RVTY
REVVITY, INC. is 1.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($12.60 B vs $8.09 B).
Revenue leader
RVTY
RVTY: $2.86B vs BIO: $2.58B.
Profit leader
BIO
RVTY: $241.20M vs BIO: $759.90M.
Margin leader
BIO
RVTY: 8.4% vs BIO: 29.4% net margin.
| Metric | RVTY | BIO |
|---|---|---|
| Market cap | $12.60 B | $8.09 B |
| US-listed rank | #821 | #1080 |
| Revenue (latest FY) | $2.86B | $2.58B |
| Net income (latest FY) | $241.20M | $759.90M |
| Net margin | 8.4% | 29.4% |
| P/E (trailing FY) | 52.2x | 10.6x |
| SEC filings | 1,745 | 1,494 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
REVVITY, INC. is 1.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($12.60 B vs $8.09 B).
In their latest fiscal years, REVVITY, INC. reported $2.86B in revenue while Bio-Rad Laboratories, Inc. reported $2.58B.
Full pages: REVVITY, INC. and Bio-Rad Laboratories, Inc., or browse the full rankings.